Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-11T00:47:11.321Z Has data issue: false hasContentIssue false
  • English
  • Français

Post-operative non-steroidal anti-inflammatory drug use for pain in infant and paediatric cardiac surgery patients

Published online by Cambridge University Press:  26 November 2019

Dimitrios A. Savva Open the ORCID record for Dimitrios A. Savva [Opens in a new window] ,
Omayma A. Kishk ,
Jill A. Morgan ,
Jessica M. Biggs ,
Hyunuk Seung  and
Caroline Bauer
Dimitrios A. Savva*
Affiliation:
Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Omayma A. Kishk
Affiliation:
Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD 21201, USA
Jill A. Morgan
Affiliation:
Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Jessica M. Biggs
Affiliation:
Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD 21201, USA
Hyunuk Seung
Affiliation:
Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Caroline Bauer
Affiliation:
Department of Pediatric Cardiac Critical Care, University of Maryland Children’s Hospital – The Children’s Heart Program, Baltimore, MD 21201, USA
*
Author for correspondence: D. A. Savva, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, 20 N Pine Street, Baltimore, MD 21201, USA. E-mail: dimitrisavva92@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Pain control is an important element of care for patients after surgery, leading to better outcomes, quicker transitions to recovery, and improvement in quality of life. The purpose of this study was to evaluate the safety and efficacy of non-steroidal anti-inflammatory drugs in children after cardiac surgery

Materials and Methods:

Patients between the ages of 1 month and 18 years of age, who received intravenous or oral non-steroidal anti-inflammataory drugs after cardiac surgery, from November 2015 until September 2017 were included in this study. The primary endpoints were non-steroidal anti-inflammataory drug-associated renal dysfunction and post-operative bleeding. Secondary endpoints examined the effect of non-steroidal anti-inflammataory drug use on total daily dose of narcotics, number of intravenous PRN narcotic doses received, and pain assessment score. Data were analysed using descriptive statistics for frequencies and ranges. Multivariate analysis was performed to measure the association of all predictors and outcomes. Wilcoxon singed-rank test was performed for secondary outcomes.

Results:

There was no association between the incidence of renal dysfunction and the use of or duration of non-steroidal anti-inflammataory drugs; in addition no association was found with increased chest tube output. There was a statistically significant reduction of patients’ median Face, Legs, Activity, Cry, Consolability (FLACC) scores (2–0; p = 0.003), seen within first 24 hours after initiation of ketorolac, and a significant reduction of morphine requirements seen from day 1 to day 2 (0.3 mg/kg versus 0.1 mg/kg; p < 0.001) and number of as-needed doses.

Conclusion:

Non-steroidal anti-inflammataory drugs in paediatric cardiac surgery patients are safe and effective for post-operative pain management.

Keywords

InfantspaediatricsNSAIDspost-operativecardiacsurgery
Type
Original Article
Information
Cardiology in the Young , Volume 29 , Issue 12 , December 2019 , pp. 1440 - 1444
Copyright
© Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jalkut, M. Ketorolac as an analgesic agent for infants and children after cardiac surgery. AACN Advanced Critical Care 2014; 25: 23–30.CrossRefGoogle ScholarPubMed
Carney, D, Nicolette, L, Ratner, M, et al. Ketorolac reduces post-operative narcotic requirements. J Pediatr Surg 2001; 36: 76–79.CrossRefGoogle ScholarPubMed
Inoue, M, Caldarone, C, Frndova, H, et al. Safety and efficacy of ketorolac in children after cardiac surgery. Intensive Care Med 2009; 35: 1584–1592.CrossRefGoogle ScholarPubMed
Oliveri, L, Jerzewski, K, Kulik, A. Black box warning: is ketorolac safe for use after cardiac surgery? J Cardiothorac Vascu Anesth 2014; 28: 274–279.10.1053/j.jvca.2013.07.014CrossRefGoogle ScholarPubMed
Moffett, B, Wann, T, Carberry, K, et al. Safety of ketorolac in neonates and infants after cardiac surgery. Pediatric Anesthesia 2006; 16: 424–428.10.1111/j.1460-9592.2005.01806.xCrossRefGoogle ScholarPubMed
Dawkins, T, Barclay, C, Gardiner, R, et al. Safety of intravenous use of ketorolac in infants following cardiothoracic surgery. Cardiol Young 2009; 19: 105–108.10.1017/S1047951109003527CrossRefGoogle ScholarPubMed
Merkel, SI, Voepel-Lewis, T, Shayevitz, JR, et al. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatric Nursing 1997; 23: 293–297.Google ScholarPubMed
Acute Kidney Injury Work Group. Kidney disease: Improving Global Outcomes (KDIGO) - clinical practice guideline for acute kidney injury. Kidney Inter 2012. 2:1–138 Google Scholar
McPherson, ML. Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing, 2nd Ed. ASHP, Bethesda, MD; in press.Google Scholar
Acharya, M, Dunning, J. Doses the use of non–steroidal anti–inflammatory drugs after cardiac surgery increase the risk of renal failure? Interact Cardiovasc Thorac Surg 2010; 11: 461–467.CrossRefGoogle ScholarPubMed
Gupta, A. Daggett, C. Ludwick, J. et al. Ketorolac after congenital heart surgery: does it increase the risk of significant bleeding complications? Pediatric Anesthesia 2005; 15: 139–142.CrossRefGoogle ScholarPubMed
Burd, R, Tobias, J. Ketorolac for pain management after abdominal surgical procedures in infants. South Med J 2002; 95: 331–333.CrossRefGoogle ScholarPubMed
Aldrink, J, Ma, M, Wang, W, et al. Safety of ketorolac in surgical neonates and infants 0 to 3 months old. J Pediatr Surg 2011; 46: 1081–1085 CrossRefGoogle ScholarPubMed